Cisatracurium (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Cisatracurium drug offered from Fresenius Kabi USA, LLC. This Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | CISATRACURIUM BESYLATE |
| SUBSTANCE NAME: | CISATRACURIUM BESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-02-26 |
| END MARKETING DATE: | 0000-00-00 |
Cisatracurium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cisatracurium from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/mL) |
| START MARKETING DATE: | 2015-02-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-416_46e6638a-7ec2-4227-b4f6-7b1f1e091ae1 |
| PRODUCT NDC: | 63323-416 |
| APPLICATION NUMBER: | ANDA203182 |
Other CISATRACURIUM BESYLATE Pharmaceutical Manufacturers / Labelers:
